India to Australia: Levothyroxine Export Trade Route
India has recorded 132 verified shipments of Levothyroxine exported to Australia, representing a combined trade value of $5.3M USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $40.5K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 72% of total export value with 85 shipments worth $3.8M USD. On the buying side, SUN PHARMA ANZ PTY LTD is the largest importer in Australia with $2.4M USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , SUN PHARMACEUTICAL INDUSTRIES LTD — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Levothyroxine corridor is one of India's established pharmaceutical export routes, with 132 shipments documented worth a combined $5.3M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 72% of all export value, reflecting the consolidated nature of India's levothyroxine manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $40.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with levothyroxine's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 20.6%, placing it at rank #13 among India's top levothyroxine export destinations globally.
On the import side, key buyers of Indian levothyroxine in Australia include SUN PHARMA ANZ PTY LTD, SUN PHARMA ANZ PTY LIMITED, SUN PHARMA ANZ PTY LTD and 3 others. SUN PHARMA ANZ PTY LTD is the single largest importer with 58 shipments valued at $2.4M USD.
